Edition:
United States

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

173.42USD
22 Jun 2018
Change (% chg)

$0.93 (+0.54%)
Prev Close
$172.49
Open
$173.83
Day's High
$174.42
Day's Low
$172.26
Volume
715,263
Avg. Vol
756,980
52-wk High
$256.78
52-wk Low
$142.83

Chart for

About

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $58,800.41
Shares Outstanding(Mil.): 339.06
Dividend: 0.72
Yield (%): 1.66

Financials

  AGN.N Industry Sector
P/E (TTM): -- 29.56 34.14
EPS (TTM): -13.47 -- --
ROI: -3.81 13.56 13.10
ROE: -6.31 15.35 15.09

Allergan appoints former Abbott executive to its board

Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.

Jun 14 2018

Allergan appoints former Abbott executive to its board

June 14 Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.

Jun 14 2018

Allergan oral migraine drug succeeds in study

June 11 Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine.

Jun 11 2018

Icahn buys small stake in drugmaker Allergan: sources

Billionaire investor Carl Icahn has acquired a small stake in Allergan Plc at a time when the drugmaker is under pressure from other activist shareholders, people familiar with the matter said on Wednesday.

Jun 06 2018

Icahn buys small stake in drugmaker Allergan -sources

June 6 Billionaire investor Carl Icahn has acquired a small stake in Allergan Plc at a time when the drugmaker is under pressure from other activist shareholders, people familiar with the matter said on Wednesday.

Jun 06 2018

Two Allergan shareholders call for split of chairman-CEO role

Two of Allergan Plc's shareholders, hedge funds Appaloosa Management and Senator Investment Group, asked the drugmaker's board to split the role of chief executive officer and chairman as well as reconsider its acquisition strategy.

Jun 05 2018

UPDATE 2-Two Allergan shareholders call for split of chairman-CEO role

June 5 Two of Allergan Plc's shareholders, hedge funds Appaloosa Management and Senator Investment Group, asked the drugmaker's board to split the role of chief executive officer and chairman as well as reconsider its acquisition strategy.

Jun 05 2018

Hedge fund Appaloosa asks Allergan to split chairman-CEO position

June 5 Billionaire investor David Tepper's hedge fund Appaloosa Management and Senator Investment Group on Tuesday asked Allergan Plc's board to split the office of the chief executive officer and chairman.

Jun 05 2018

Federal Circuit weighs validity of Allergan patent deal with tribe

A federal appeals court on Monday appeared divided on whether a deal by which pharmaceutical company Allergan PLC transferred drug patents to a Native American tribe would shield them from administrative review.

Jun 04 2018

Pershing Square's Fraidin to join Cadwalader as M&A lawyer

BOSTON Stephen Fraidin, a prominent mergers lawyer who has been a top executive at billionaire investor William Ackman's hedge fund, is joining law firm Cadwalader, Wickersham & Taft LLP.

Jun 04 2018

Earnings vs. Estimates